10:01:46 EDT Mon 19 Aug 2019
Enter Symbol
or Name

Login ID:

News for U:WXXWY from 2018-08-20 to 2019-08-19 - 36 items News ReleasesIn The NewsOther
2019-06-20 20:22WXXWYNews ReleaseWuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing
2019-06-04 21:05WXXWYNews ReleaseWuXi Biologics Hosts Successful Inaugural Investor Day
2019-05-20 19:28WXXWYNews ReleaseWuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract
2019-05-16 03:28WXXWYNews ReleaseWuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu
2019-04-16 21:00WXXWYNews ReleaseWuXi Biologics Successfully Completed First FDA Routine GMP Inspection
2019-04-16 07:53WXXWYNews ReleaseWuXi Biologics and I-Mab Biopharma Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs
2019-04-08 20:25WXXWYNews ReleaseWuXi Biologics and NBE-Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership
2019-04-03 08:01WXXWYNews ReleaseWuXi Biologics Wins 2019 CMO Leadership Awards in All Six Core Categories
2019-03-25 20:21WXXWYNews ReleaseWuXi Biologics Receives "Asia's Best CMO of 2018" Award from IMAPAC
2019-03-19 20:07WXXWYNews ReleaseWuXi Biologics Receives EMA GMP Certificates
2019-03-18 10:21WXXWYNews ReleaseWuXi Biologics Continues to Deliver Record Results
2019-02-27 20:33WXXWYNews ReleaseWuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA
2019-02-25 19:20WXXWYNews ReleaseABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million
2019-02-18 19:21WXXWYNews ReleaseEMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics
2019-02-11 19:00WXXWYNews ReleaseWuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership
2018-12-19 07:13WXXWYNews ReleaseWuXi Biologics and AC Immune to Establish an Exclusive Strategic Partnership
2018-12-12 18:30WXXWYNews ReleaseWuXi Biologics Congratulates Tychan on First-in-Class Monoclonal Antibody for Yellow Fever after Record 7 Months of Development
2018-12-11 18:51WXXWYNews ReleaseWuXi Biologics Achieves Breakthrough Titer of 51g/L in Cell Culture Productivity
2018-12-10 20:47WXXWYNews ReleaseOxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody ™ Platform for Five Bispecific Antibody Programs for up to $450 Million
2018-12-09 21:21WXXWYNews ReleaseWuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel Bispecific Antibody Immunotherapeutics
2018-12-06 05:12WXXWYNews ReleaseWuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market"
2018-12-05 09:54WXXWYNews ReleaseWuXi Biologics Commenced Construction of the Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland
2018-11-29 08:22WXXWYNews ReleaseWuXi Biologics Selected as Forbes Asia's Best Under A Billion 2018
2018-11-28 06:44WXXWYNews ReleaseWuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies
2018-11-22 01:31WXXWYNews ReleaseWuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai
2018-11-07 04:43WXXWYNews ReleaseWuXi Biologics' Chief Executive Officer Dr. Chris Chen to Serve on Board of Directors at ISPE and Delivered Keynote Speech at 2018 Annual Meeting
2018-10-31 08:14WXXWYNews ReleaseWuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang
2018-10-31 04:08WXXWYNews ReleaseWuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang
2018-10-29 08:03WXXWYNews ReleaseWuXi Biologics Congratulates Tychan on Completing Human Safety Studies for the First-in-Class Zika Virus Antibody in Record Speed
2018-10-23 08:00WXXWYNews ReleaseCANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics
2018-09-26 07:01WXXWYNews ReleaseI-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Three Bispecific Antibody Programs
2018-09-24 20:00WXXWYNews ReleaseWuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board
2018-09-17 20:00WXXWYNews ReleaseWuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA
2018-09-10 20:35WXXWYNews ReleaseWuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manufacturing
2018-08-29 22:08WXXWYNews ReleaseWuXi Biologics Selected into the Hang Seng HK 35 Index
2018-08-20 08:25WXXWYNews ReleaseWuXi Biologics Reports Robust 2018 Interim Results